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The purpose of the present work was to evaluate the synergistic effect of ionization type,
sample preparation technique, and bio-fluid on the presence of matrix effect in quantitative
liquid chromatography (LC)-MS/MS analysis of illicit drugs by post-column infusion exper-
iments with morphine (10-g/mL solution). Three bio-fluids (urine, oral fluid, and plasma)
were pretreated with four sample preparation procedures [direct injection, dilution, protein
precipitation, solid-phase extraction (SPE)] and analyzed by both LC-electrospray ionization
(ESI)-MS/MS and LC-atmospheric pressure chemical ionization (APCI)-MS/MS. Our results
indicated that both ionization types showed matrix effect, but ESI was more susceptible than
APCI. Sample preparation could reduce (clean up) or magnify (pre-concentrate) matrix effect.
Residual matrix components were specific to each bio-fluid and interfered at different time
points in the chromatogram. We evaluated matrix effect in an early stage of method
development and combined optimal ionization type and sample preparation technique for
each bio-fluid. Simple dilution of urine was sufficient to allow for the analysis of the analytes
of interest by LC-APCI-MS/MS. Acetonitrile protein precipitation provided both sample clean
up and concentration for oral fluid analysis, while SPE was necessary for extensive clean up
of plasma prior to LC-APCI-MS/MS. (J Am Soc Mass Spectrom 2003, 14, 1290–1294) © 2003
American Society for Mass Spectrometry
Over the last decade, liquid chromatography(LC) combined with mass spectrometry (MS)has become a powerful analytical tool [1–5]. A
breakthrough was the introduction of two atmospheric
pressure ionization (API) interfaces, electrospray ion-
ization (ESI) [6, 7] and atmospheric pressure chemical
ionization (APCI) [8]. Today, LC-MS has evolved into a
technique characterized by sensitivity, selectivity, and
specificity, allowing for the analysis of trace amounts of
target analytes in complex mixtures. Based on these
characteristics, one would expect that sample prepara-
tion prior to analysis could be minimized or even
eliminated. Simplification of sample preparation would
reduce time-consuming method development and sam-
ple analysis time during routine application of the
method.
One limitation associated with LC-MS analysis is its
susceptibility to matrix effect [9, 10]. Matrix effect is
defined as the effect of co-eluting residual matrix com-
ponents on the ionization of the target analyte. Typi-
cally, suppression or enhancement of analyte response
is accompanied by diminished precision and accuracy
of subsequent measurements [11–13]. Matrix effect thus
limits the utility of LC-MS for quantitative analysis.
In an effort to reduce sample preparation time for
hundreds of biological samples collected in clinical
studies at NIDA, we aimed to simplify sample prepa-
ration prior to LC-MS/MS analysis. However, we rec-
ognized that the presence of residual matrix compo-
nents after sample pretreatment could seriously
jeopardize the precision and accuracy of the quantita-
tive analyses. The purpose of the present work was the
evaluation of matrix effects due to the combination of
bio-fluid, sample preparation technique, and ionization
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type. Urine and oral fluid were pretreated by four
common sample preparation techniques—direct injec-
tion, dilution, protein precipitation, and solid-phase
extraction (SPE)—and analyzed by LC-MS/MS. Due to
the high protein content of plasma and the subsequent
high “clogging” risk for the analytical column, direct
injection and dilution were not evaluated for this bio-
fluid. All bio-fluid extracts were analyzed by both
LC-ESI-MS and LC-APCI-MS. Matrix effect was evalu-
ated by post-column infusion of morphine during
LC-MS analysis of blank pretreated bio-fluid samples.
The information obtained from this study was used to
pair the optimal sample preparation technique and
ionization type for the quantitation of illicit drugs and
opioid therapeutic medications in a given bio-fluid.
Experimental
Morphine was purchased from Cerilliant (Austin, TX).
A 10-g/mL morphine working solution was prepared
by dilution with methanol/acetonitrile (50:50). All re-
agents were of ACS grade or higher, with solvents of
HPLC grade or higher. Blank human plasma was ob-
tained from the Johns Hopkins Bayview Medical Center
blood bank (Baltimore, MD). Drug-free oral fluid and
urine were obtained from healthy volunteers. Oral fluid
was collected with a Salivette device with neutral cotton
wool (Sarstedt, Nu¨mbrecht, Germany). All samples
were stored at 20 °C until use.
Four different sample preparation procedures were
investigated: direct injection, dilution, protein precipi-
tation and SPE. Prior to direct injection of 100 L of
bio-fluid onto the LC-MS system, 400 L of a given
sample was centrifuged at 510  g for 5 min. In the case
of sample dilution, 200 L of sample was combined
with 200 L of a mixture of 10 mM aqueous ammonium
formate (pH 4.5) and acetonitrile (97:3), vortexed, cen-
trifuged (5 min at 510  g), and 100 L injected. Protein
precipitation was performed by addition of 600 L of
acetonitrile to 200 L of sample, vortexing for 30 s, and
centrifugation at 15,996 g for 10 min. The supernatant
was evaporated to dryness under nitrogen at 45 °C. The
dried sample was reconstituted in 200 L of 10 mM
aqueous ammonium formate (pH 4.5) and acetonitrile
(97:3), and 50 L injected. SPE was performed with
200-mg Clean-Screen DAU columns (United Chemical
Technologies Inc., Bristol, PA). The SPE procedure for
the analysis of cocaine, opiates, and metabolites in
biofluids has been published previously [14]. Briefly, 1
mL of sample was combined with 3 mL 2M sodium
acetate buffer (pH 4.0). After conditioning the column,
the sample was applied. Subsequently, the column was
washed with 2 mL of water, 1.5 mL of 0.2M hydrochlo-
ric acid, and 2 mL of methanol. The column was dried
under vacuum and eluted with 4 mL of elution solvent
[methylene chloride:isopropanol:ammonium hydrox-
ide (30%) (40:10:1)]. The eluate was dried under nitro-
gen, reconstituted in 200 L of 10 mM ammonium
formate in water (pH 4.5) and acetonitrile (97:3), and 50
L injected.
All LC-MS experiments were carried out on an LCQ
Deca XP Ion Trap Mass Spectrometer, equipped with an
orthogonal APCI or ESI source, and interfaced to a
Surveyor HPLC system (ThermoFinnigan, San Jose,
CA). A chromatographic method was developed using
a Synergi Polar RP column (150  2.0 mm, 4 m), fitted
with an identically packed guard column (4  2.0 mm)
(Phenomenex, Torrance, CA). The column oven was
maintained at 25 °C. The following gradient elution
with 10 mM aqueous ammonium formate, 0.001% for-
mic acid (pH  4.5) as “A” and acetonitrile as “B” was
used at a flow rate of 300 L/min: 0–13 min: 5% B 3
26% B; 13–22 min: 26% B3 90% B; 22–24 min: 90% B3
90% B; 24–27 min: 90% B3 5% B, and 27–35 min: 5% B.
All MS/MS data for morphine were collected in posi-
tive ion mode by selected reaction monitoring (SRM) of
the transition m/z 286.3 3 m/z 268.3, 229.1, 211.2. The
optimized parameter settings for ESI were: spray volt-
age, 4.0 kV; sheath gas, 50; auxiliary gas, 20 (both
high-purity nitrogen). The APCI parameter settings
were: corona discharge needle voltage, 4.5 kV; vapor-
izer temperature, 450 °C; sheath gas (high-purity nitro-
gen), 70; and no auxiliary gas. Transfer capillary tem-
perature and electron multiplier voltage were set at 220
°C and 850 eV, respectively, for both ESI and APCI.
Matrix effect was evaluated by the experimental
technique developed by Bonfiglio et al. [15]. A blank
pretreated bio-fluid sample was injected during contin-
uous post-column infusion of a 10-g/mL morphine
solution at a flow rate of 5 L/min. The affected area of
the chromatographic run was determined by compar-
ing the SRM chromatographic profiles for morphine
obtained with an injection of the blank pretreated
bio-fluid and an equivalent injection of mobile phase.
Each experiment was performed in duplicate.
Results
Matrix effect was evaluated during method develop-
ment of the simultaneous analysis of 25 opioids, cocaine
and metabolites in three different bio-fluids. All ana-
lytes of interest eluted within 26 min with the gradient
specified [16]. An example of the SRM profiles of
morphine obtained during LC-ESI-MS/MS analysis of
oral fluid pretreated by acetonitrile protein precipita-
tion (Figure 1b) is compared to that obtained by injec-
tion of an equal volume of mobile phase (Figure 1a).
The differences in the RICs illustrate signal suppression
of 70% from 1–2 min, 15% from 2–8 min, and 50% from
17.5–22 min. Conversely, the same experiment using
APCI showed no signal suppression (Figure 2).
Table 1 provides an overview of the results obtained
with the continuous post-column infusion experiments.
The different time intervals of the chromatographic
analysis affected by matrix effect, as well as, the extent
of the effect (%) are documented for each combination
of bio-fluid, sample preparation technique, and ioniza-
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tion type. For reporting purposes, matrix effect was
expressed as the percentage of suppression or enhance-
ment. The authors are fully aware of the variable nature
of matrix effect. Therefore, the percent matrix effect is a
relative indicator of the degree of suppression or en-
hancement.
Discussion
Post-column infusion of morphine provided rapid vi-
sualization of the effect of interfering species on the
ionization of the target analyte, indicating areas of the
LC gradient affected by matrix effect. Although mor-
phine had a retention time of 7.6 min with the stated
HPLC gradient, it was considered a good indicator of
ion suppression or enhancement across the entire chro-
matographic run [19]. Post-column infusion of mor-
phine allowed us to assess the efficiency with which
four common sample preparation techniques removed
matrix components from three bio-fluids and to study
the effect of residual matrix components on the ioniza-
tion of the target . Due to the analyte dependent nature
of matrix effect, caution needs to be taken when corre-
lating these results to other analytes of interest.
Matrix effect was observed with both ionization
types, but was more prevalent with ESI than APCI. ESI
was clearly affected by components with a wide polar-
ity range, making this type of ionization highly suscep-
tible to matrix effect. APCI proved less susceptible to
matrix effect than ESI [11, 17, 18], especially in the
presence of hydrophobic interferences. Suppression
was only observed in the beginning of the chromato-
grams for all three matrices. This is likely due to the
Figure 1. Post-column infusion chromatogram of morphine for
LC-ESI-MS/MS analysis of (A) blank mobile phase injection and
(B) oral fluid pretreated by acetonitrile protein precipitation.
Figure 2. Post-column infusion chromatogram of morphine for
LC-APCI-MS/MS analysis of (A) blank mobile phase injection and
(B) oral fluid pretreated by acetonitrile protein precipitation.
Table 1. Results of post-column infusion experiments, showing time (minutes) and extent (%: suppression; %: enhancement) of
the observed matrix effects
Electrospray Ionization
Urine Oral fluid Plasmab
Direct injection 1–2 min: 90% 1–2 min: 70%
8–9.5 min: 20%
Dilution 1–2 min: 60–95% NDa
Protein precipitation 1–2 min: 85% 1–2 min: 70% 1–2.5 min: 75%
2–8 min: 15% 17.5–22 min: 50% 20–22 min: 65%
18–18.5 min: 20% 22.5–23 min: 150%
Solid-phase 1–2 min: 40% 1–2 min: 10% 1–2 min: 35%
Extraction 8 min: 30% 12–20 min: 10–15% 20–22 min: 50%
Atmospheric pressure chemical ionization
Urine Oral fluid Plasmab
Direct injection 1–2.5 min: 97.5% NDa
6–7 min: 50%
Dilution 1–2 min: 70% NDa
Protein precipitation 1–2 min: 99% NDa 1–2.5 min: 60%
5.5 min: 40%
6–6.5 min: 50%
Solid-phase extraction 1–3 min: 20% 1–3 min: 20% NDa
aMatrix effect not detected.
bdirect injection and dilution were not evaluated for plasma.
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different ionization process, with APCI based on gas-
phase reactions and ESI mainly on liquid-phase reac-
tions [10, 19].
Large differences in matrix effect were also observed
between sample preparation techniques. In general,
acetonitrile protein precipitation in combination with
LC-ESI-MS/MS had the greatest matrix effect, with
major suppression areas in the beginning and end of the
chromatographic separation. Due to the non-selective
nature of protein precipitation as a sample pretreat-
ment, clean up of the bio-fluid is minimal. The combi-
nation of large amounts of residual matrix components
and ESI clearly demonstrated matrix effects. These
findings agree with results previously reported in the
literature [15].
SPE, often proposed as a solution for matrix effect,
also had suppression when used in conjunction with
LC-ESI-MS/MS. Although matrix clean up is more
extensive with SPE, the pre-concentration step in-
creased the concentration of target analytes but also
increased the concentration of interfering substances
from the bio-fluid and/or sample preparation. We
concluded that the SPE pre-concentration step magni-
fied matrix effect. Additionally, we noted that direct
injection and dilution, two sample preparation methods
without a pre-concentration step, had much less sup-
pression in LC-ESI-MS/MS. However, the drawback of
omitting a pre-concentration step from the sample
preparation procedures is a loss in sensitivity and an
increase in limits of detection.
The presence of matrix effect also proved to be
dependent on the bio-fluid analyzed. Matrix compo-
nents, characteristic to each bio-fluid, interfered at dif-
ferent times and to a varying extent throughout the
analysis. The major interferences in urine proved to be
hydrophilic residual components, most likely inorganic
salts. Oral fluid had more interferences than urine,
mainly in ESI, and residual matrix components were of
a hydrophilic and hydrophobic nature, including pro-
teins, amino acids, and especially mucin. Finally, for
plasma, residual matrix components also had a wide
polarity range, but their concentrations were apparently
higher than those of oral fluid.
Conclusions
Our results indicated that matrix effect was dependent
on ionization type, sample preparation, and bio-fluid
type. When matrix effect resulted in severe ion suppres-
sion or enhancement of the target analyte by co-eluting
residual components, it was located in isolated regions
of the chromatogram. Although matrix effect was ob-
served for both ionization types, ESI was especially
susceptible, while APCI proved to be less vulnerable.
Sample preparation had a clear influence on matrix
effect. Although a more extensive clean up generally
yielded cleaner extracts, pre-concentration of matrix
components during sample preparation magnified ma-
trix effect. However, pre-concentration is often neces-
sary to obtain adequate sensitivity. Each bio-fluid was
characterized by endogenous matrix components that
caused different matrix effects.
In conclusion, LC-APCI-MS/MS is the ionization of
choice for quantitative analysis of multiple illicit and
therapeutic drugs. APCI allowed for simplification of
sample preparation prior to analysis without jeopardiz-
ing the quality of quantitative data. The selection of
sample pretreatment for each bio-fluid was dependent
upon expected analyte concentrations and required
detection limits. For urine, the expected high concentra-
tion of metabolites allowed for a simple dilution of
sample prior to analysis. In the case of oral fluid,
expected analyte concentrations were much lower and
pre-concentration was needed. Acetonitrile protein pre-
cipitation provided sufficient pre-concentration and
protein removal for quantitative analysis of the analytes
of interest in oral fluid. Finally, matrix suppression data
indicated that solid-phase extraction was required prior
to LC-APCI-MS/MS analysis of the analytes of interest
in plasma.
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